High-Purity USP37 Tenofovir Disoproxil Fumarate/TDF Cas no.202138-50-9

Min.Order / FOB Price:Get Latest Price

1 Milligram	FOB Price: USD 0.1000

1 Milligram

FOB Price: USD 0.1000

Min.Order :1 Milligram
Purity: 99%
Payment Terms : L/C,D/A,D/P,T/T,,MoneyGram,Other

Keywords

Tenofovir Disoproxil Fumarate 202138-50-9 TDF

Quick Details

Appearance:White Powder
Application:CAS No. 202138-50-91. 1.Anti-HIV drug 2.Anti-HBV drug
PackAge:1Kg/bag;25Kg/drum or as request
ProductionCapacity:1000|Kilogram|Month
Storage:Protected from light,stored hermetically and in a dry place
Transportation:Air/SEA

Superiority:

Specifications:

Name: Tenofovir disoproxil fumarate

CAS: 202138-50-9

Specification: EP/USP

Top quality,best price

Details:

Description:

1. English Name: Tenofovir Disoproxil Fumarate

2. Chemical Name: 9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine fumarate

3. CAS No.: 202138-50-9

4. MF: C23H34N5O14P

5. Appearance: White Powder

Tenofovir disoproxil fumarate (TDF or PMPA), is a prodrug form of tenofovir. It is also marketed under the brand name Reviro by DRL. Tenofovir is also available in a fixed-dose combination with emtricitabine in a product with the brand name Truvada for once-a-day dosing. Atripla, a fixed-dose triple combination of tenofovir, emtricitabine and efavirenz, was approved by the FDA on 12 July 2006 and is now available, providing a single daily dose for the treatment of HIV.

Usage:

1. Tenofovir is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older.

2. Tenofovir is indicated for the treatment of chronic hepatitis B in adults and pediatric patients 12 years of age and older.

Our Package:

Packaging Detail	25kg/durm, paper-drums and two plastic-bags inside and Can be customerized
Storage	Store in a well-closed container away from moisture
Shelf Life	2 years if sealed and store away from direct sun light.